Expressive Wealth LLC Acquires New Position in Celestica, Inc. $CLS

Expressive Wealth LLC acquired a new stake in Celestica, Inc. (NYSE:CLS) (TSE:CLS) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 1,784 shares of the technology company’s stock, valued at approximately $651,000.

A number of other institutional investors have also recently bought and sold shares of CLS. NewGen Equity Long Short Fund bought a new stake in shares of Celestica during the 2nd quarter valued at $14,050,000. Northwestern Mutual Wealth Management Co. grew its stake in shares of Celestica by 7,646.2% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,007 shares of the technology company’s stock worth $157,000 after purchasing an additional 994 shares during the period. First Trust Advisors LP grew its stake in shares of Celestica by 30.0% during the second quarter. First Trust Advisors LP now owns 78,061 shares of the technology company’s stock worth $12,197,000 after purchasing an additional 18,025 shares during the period. NewEdge Advisors LLC increased its holdings in Celestica by 385.8% in the second quarter. NewEdge Advisors LLC now owns 2,803 shares of the technology company’s stock valued at $438,000 after purchasing an additional 2,226 shares during the last quarter. Finally, HUB Investment Partners LLC increased its holdings in Celestica by 11.0% in the second quarter. HUB Investment Partners LLC now owns 3,181 shares of the technology company’s stock valued at $497,000 after purchasing an additional 315 shares during the last quarter. Institutional investors and hedge funds own 67.38% of the company’s stock.

Celestica Stock Performance

Shares of Celestica stock opened at $296.03 on Friday. The stock’s fifty day simple moving average is $341.15 and its 200 day simple moving average is $335.16. The company has a current ratio of 1.23, a quick ratio of 0.68 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $34.04 billion, a PE ratio of 30.77 and a beta of 2.06. Celestica, Inc. has a 12 month low of $179.01 and a 12 month high of $474.02.

Celestica (NYSE:CLS) (TSE:CLS) last posted its earnings results on Monday, July 27th. The technology company reported $2.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.29 by $0.25. Celestica had a return on equity of 39.96% and a net margin of 7.16%.The firm had revenue of $4.68 billion during the quarter, compared to analysts’ expectations of $4.30 billion. During the same period in the previous year, the firm earned $1.39 earnings per share. The company’s revenue was up 62.4% on a year-over-year basis. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. On average, research analysts predict that Celestica, Inc. will post 10.15 EPS for the current year.

Insider Activity

In other news, CEO Robert Mionis sold 98,453 shares of Celestica stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $368.99, for a total transaction of $36,328,172.47. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Mandeep Chawla sold 17,000 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $399.65, for a total value of $6,794,050.00. Following the completion of the transaction, the chief financial officer owned 82,444 shares of the company’s stock, valued at $32,948,744.60. This represents a 17.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 356,553 shares of company stock worth $135,238,444 in the last quarter. 1.10% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on CLS shares. Citigroup raised their target price on Celestica from $338.00 to $415.00 and gave the stock a “buy” rating in a report on Wednesday, April 29th. Zacks Research raised Celestica from a “hold” rating to a “strong-buy” rating in a research note on Friday, June 26th. Barclays cut their price target on shares of Celestica from $430.00 to $406.00 and set an “overweight” rating on the stock in a research report on Friday, August 7th. Susquehanna lifted their price objective on shares of Celestica from $460.00 to $510.00 and gave the stock a “positive” rating in a research note on Wednesday, April 29th. Finally, UBS Group restated a “neutral” rating and set a $410.00 price objective on shares of Celestica in a report on Wednesday, July 29th. One investment analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $438.86.

Celestica Company Profile

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.